José Maria Abad Diez

TL;DR: The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented and a specific focus on older patients is focused on.

TL;DR: The incidence of patients starting RRT pmp secondary to DM in Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower than the USA, when compared with the USA.

TL;DR: Infection-related mortality is highly increased in dialysis and kidney transplant patients, while the risk of malignancy-related death is moderately increased, and young women on dialysis may deserve special attention because of their high excess risk of infection- related mortality.

TL;DR: This article presents the incidence and prevalence of RRT, and renal transplant rates in 2011, from national and regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea and describes the highest and lowest prevalence reported by Portugal and Turkey.

TL;DR: More than two-thirds of patients initiating RRT in Europe have at least one co-morbidity, and with the rising age at the start of RRT over the last decade, there have been changes in the co-Morbidity pattern.